• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Jan. 28

    Alleviant Medical Closes $75M Financing Round

    Know Labs Founder Ron Erickson Named CEO

    Getinge's Recall of Cardiosave Hybrid and Rescue IABPs is Class I

    FDA OKs Tidepool Loop App Connecting CGMs, Insulin Pumps
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Halkey-Roberts Corporation

    Arthur G. Russell Co. Inc., The

    Forefront Medical Technology

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Halkey-Roberts Corporation

    Arthur G. Russell Co. Inc., The

    Forefront Medical Technology

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Georgia Facility Lends a Commercial Eye to Medical Innovation

    Atlanta's Global Center for Medical Innovation guides medtech developers from breakthrough concepts to commercial products.

    Georgia Facility Lends a Commercial Eye to Medical Innovation
    Related CONTENT
    • MEDICAL & BIOTECH MANUFACTURING
    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    • Accu-Tube Appoints Matthew Haddle as CEO
    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    • CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Sam Brusco, Associate Editor11.07.16
    In the heart of Atlanta—midtown, to be precise—sits a somewhat unassuming building that many commuters on their way downtown might not even glance at during their drive. It’s one story tall, has a slight nondescript flavor, and doesn’t overtly advertise itself to oncoming traffic.
     
    It’s also the site of breakthrough, yet unheard of medical device development projects—about 70 in the last 3 years, in fact. Courtesy of the Georgia Department of Economic Development, I was privileged enough to tour this facility, which is known as the Global Center for Medical Innovation, or GCMI.

    For those yet unaware, GCMI isn’t an engineering, prototyping, device testing, quality assurance, or consulting facility, nor is it an incubator. More aptly put, it’s not just any of those; it’s all of them. Since opening its doors in April 2012, GCMI has partnered with over 50 different startups, clinicians, university tech transfer offices, and academic researchers to bring their medical devices from concept to market, offering a variety resources along the way.
     
    A lean, non-profit facility that takes on high-risk medical device ventures that corporations tend to shy away from, GCMI seeks to lend a commercial eye to innovation. It’s part of a medtech “value chain” that exists in Georgia that includes nearby universities like Georgia Tech and Emory; industry pioneers like C.R. Bard, Elekta, and Stryker; and start-ups like CardioMEMS. (The latter of these actually passed through the GCMI before being acquired by St. Jude Medical in 2014 for a cool $455 million.) GCMI stands in the gap between innovation and industry, offering medical device developers a helping hand—and an impressively well-equipped facility—for eventually getting their products into the hands of patients.


    Georgia Tech President G.P. “Bud” Peterson (left) shares his insights on medical device innovation with Julie Lenzer Kirk (center), the director of U.S. Commerce Department's Office of Innovation and Entrepreneurship and GCMI CEO Tiffany Wilson (right). GCMI is a Georgia Tech affiliate. (Courtesy of Georgia Tech)

     
    In order to gain some insight on how GCMI assists fledgling medical device developers in getting their projects to market, MPO spoke with Tiffany Wilson, chief executive officer of GCMI and T3 Labs, a preclinical testing and training services facility that GCMI acquired in late July.
     
    Sam Brusco: What are your criteria for accepting a project into the GCMI?

    Tiffany Wilson: We operate on a fee for service basis, so at a minimum innovators should have some level of funding for us to accept a project. We then assess projects on our ability to add value and help the innovator or startup achieve value added milestones to reach go/no-go decisions. Ideally, the startup team embraces a collaborative spirit and is ready to actively work with our team to move the project forward.
     
    Brusco: Where in the product development cycle does GCMI usually get involved? 

    Wilson: The earlier the better—but we can get involved as early as an idea or an unmet clinical need that needs to be addressed, or as late as a product on the market that needs to be re-designed. Our goal is to help accelerate the development and commercialization of new medical technologies so patients can benefit and the medtech startup industry can thrive, so we jump in where we can to help make that happen.
     
    Brusco: Which in-house services (engineering, prototyping, testing, consulting, etc.) does GCMI offer to startups? Do you offer financial consulting as well?
     

    Wilson: Through GCMI and T3 Labs, we have an in-house team of design/biomedical engineers, medtech product development expertise, clinical evaluation, and preclinical testing. Our "ecosystem" includes a broad range of experts and consultants across the continuum, including legal, patent, material properties, electronics, software, regulatory, quality, reimbursement, clinical, and investors. We build project teams based on the critical needs and pathway for the startup. We work with investors to help startups make sure they are investor ready and can address key points in the due diligence process.
     
    Brusco: Though GCMI is a non-profit, how do you accrue the funding to keep the wheels turning?

    Wilson: While we got off the ground with tremendously helpful grant dollars from the U.S. Department of Commerce and the Georgia Research Alliance, both GCMI and T3 Labs operate on a fee for service basis. We have been able to do this and grow by providing excellent customer service, quality work, and being able to do what we said we could do. Moving forward, there are a number of new programs we are launching in 2017 that will grow the level of funding required to expand our capabilities, hire additional expertise, and support the most innovative technologies and startups on their journey from concept to commercialization.
     
    Brusco: What challenges are involved in bringing university-born medtech innovations to market? 

    Wilson: The main challenge we see is that university innovators do not always appreciate the complexity of taking an invention or an initial prototype and turning that into a regulated product. There is usually a lot of education and discussion around that process. We also see university innovations developed in a vacuum vs. based on customer-based feedback and specifications—i.e., technology looking for a problem to solve rather than addressing true unmet clinical needs. Finally, the technology transfer process and finding the right business partner can be tricky.
     
    Brusco: How does GCMI assist university-born startups in entering the medtech market?

    Wilson: At the most basic level, we can help take IP and quickly develop basic market assessment and proof-of-concept prototypes to see if the startup pathway looks promising. We can then put together a product development strategy and help build a team around the startup to help identify critical milestones and quality plan that will be required as the startup moves from grant funding that is available to university spinouts to early stage investors and venture capital.
     
    Brusco: When would you consider a project to be “ready” to leave the GCMI?

    Wilson: It depends on the technology and the team. We see a project as a success if we can provide a way for an innovator or entrepreneur to fail quickly and inexpensively or move out of the incubator so they can scale—or anywhere in between. If we can help someone hit a milestone or answer a question quickly, easily, and in a capital efficient way, that's a win.
     
    Brusco: Lastly, what are the 3 most common bits of advice you offer startups passing through the GCMI?

    Wilson: Start thinking about design controls and your quality system. Now.
    Understand your customer(s) and keep them in the loop throughout.
    Plan. Hit the pause button for a moment to do your homework, understand what milestones investors are going to want to see, what data FDA and CMS need to see, and what specifications are critical for customers to see.
    Related Searches
    • medical
    • start-ups
    • eye
    • fda
    Related Knowledge Center
    • Testing
    • R&D & Design
    • Software & IT
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Molli Surgical Molli Surgical's Breast Tumor Marker
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    RapidPulse Closes $15 Million Series A Financing RapidPulse Closes $15 Million Series A Financing
    Midwest Products & Engineering Acquires MindFlow Design Midwest Products & Engineering Acquires MindFlow Design
    Vicarious Surgical Opens New Corporate Headquarters in Massachusetts Vicarious Surgical Opens New Corporate Headquarters in Massachusetts
    Luis J. Malavé Joins Integrity Applications Board Luis J. Malavé Joins Integrity Applications Board

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21

    • Tubing & Extrusion
      Accu-Tube Appoints Matthew Haddle as CEO

      Accu-Tube Appoints Matthew Haddle as CEO

      Haddle has a track record of leading organizations through strategic expansions across the medical device, aerospace, and industrial sectors.
      Accu-Tube 09.22.21


    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    • CE Mark Granted to Predictive Software for Kidney Allograft Survival

      CE Mark Granted to Predictive Software for Kidney Allograft Survival

      Algorithm gives the probability the graft will still be functional at three, five, and seven years after evaluation by a healthcare professional.
      Cibiltech 09.21.21

    Loading, Please Wait..

    Trending
    • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
    • Promising Study Results Released For Uncontrolled Hypertension Treatment
    • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
    • BMP Medical Expands Sterling, Massachusetts Facility
    • FDA OKs Tidepool Loop App Connecting CGMs, Insulin Pumps
    Breaking News
    • MPO's Most-Read Stories This Week—Jan. 28
    • Alleviant Medical Closes $75M Financing Round
    • Know Labs Founder Ron Erickson Named CEO
    • Getinge's Recall of Cardiosave Hybrid and Rescue IABPs is Class I
    • FDA OKs Tidepool Loop App Connecting CGMs, Insulin Pumps
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Nutrasource Rebrands Clinical Trial Site to Apex Trials
    Kerry Sponsors Upcycled Food Foundation Research Fellowship
    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Jan. 28
    Alleviant Medical Closes $75M Financing Round
    Know Labs Founder Ron Erickson Named CEO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    SK bioscience Introduces New Global Partnership Model for Vaccines
    Merck's KEYTRUDA Wins Expanded Approval in Non-Small Cell Lung Cancer
    Bone Biologics Engages Avania for NB1 Clinical Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    LVMH Reports Record 2022
    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Happi

    Latest Breaking News From Happi

    Alix Earle, Jonathan Monroe Are Fast-Growing Beauty Influencers on Instagram
    Fragrance Creators Launches First-of-its-Kind Data Insights Program
    The Lip Bar Enters the Skin Care Category with First-Ever Skincare Collection
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Sustainability and Pigments, TSCA and Raw Materials Top This Week’s Stories
    Roland DGA Announces Major Expansion of TrueVIS Printer Family
    Neos Expands Production Capacity, European Market Presence
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Channeled Resources launches blank labels with PET liner
    Infigo partners with Four Pees in Benelux region
    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Jan. 28
    Roche, Sysnav Partner on Movement Tracking Tech for Neuromuscular Disorders
    Orthopedic Braces/Support, Casting/Splints Market to Top $12B by 2030
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Avery Dennison, CES 2023 and Canatu’s LiDAR Deicing Top This Week’s Stories
    Celanese Launches Nine New Conductive Inks
    NREL Develops Thin, Lightweight Layer for Radiation Barrier for Perovskites in Space

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login